Professor Paul Cohen and Associate Professor Yoland Antill present highlights from the recent ESGO's 25th Congress held in Barcelona, Spain, from March 7-10, 2024. What is ESGO? The European Society of Gynaecological Oncology (ESGO) is [...]
Patient involvement in research within the Gynecologic Cancer InterGroup: A call to action for a systematic approach: Results from a survey Patient involvement in clinical research development has gradually expanded over the last two decades, creating [...]
ANZGOG Chair, Professor Clare Scott AM presents highlights from the recent ESMO conference, held in Madrid, Spain, 20-24 October 2023. What is ESMO 2023? To stay at the forefront of clinical trial opportunities for our [...]
Led by ANZGOG co-founder Professor Michael Friedlander AM, PARAGON was one of ANZGOG's first practice-changing studies. The publications arising from the insights and data collected because of this pivotal trial continue to contribute to research on [...]
In celebration of their 20 year anniversary, ANZGOG is pleased to share the commemorative publication: ‘20 Years Improving Life for Women Through Cancer Research, Part Two.’ In Part Two of '20 Years Improving Life [...]
The Ovarian Cancer Advances Summit (OVAS) 2021 will explore a multi-disciplinary approach to managing patients with ovarian cancer. OVAS 2021 will be hosted by an independent steering committee featuring ANZGOG members, Prof Clare [...]
ANZGOG is pleased to announce that Survivors Teaching Students® (STS), the ground-breaking education program, has commenced in New Zealand. STS is a volunteer program that brings the faces and voices of ovarian and other gynaecological cancer [...]
A new journal has been published by the Journal for ImmunoTherapy of Cancer for ANZGOG's PHAEDRA study. The PHAEDRA study examined the activity of the immunotherapeutic agent durvalumab in women with advanced endometrial cancer that [...]
A significant international study in cervical cancer treatment, the ANZGOG-led OUTBACK trial will be presented at the 2021 ASCO Annual Meeting Plenary Session to reveal its highly anticipated results. OUTBACK is an academic collaboration [...]
In recent news, the American Society of Clinical Oncology (ASCO) has selected OUTBACK, an ANZGOG cervical cancer study, to be presented during the Plenary Session at their upcoming 2021 Annual Meeting. OUTBACK is an international trial [...]
Australia New Zealand Gynaecological Oncology Group www.anzgog.org.au
Level 6, Lifehouse, 119-143 Missenden Road Camperdown NSW 2050 T:+61 2 8071 4880
E: contact@anzgog.org.au © 2024 ANZGOG | Copyright | Disclaimer | ANZGOG Policies | Whistleblower
Virtually every advance in cancer survival has been made on the back of clinical trials.
As the peak, national gynaecological cancer clinical trials organisation for Australia and New Zealand, ANZGOG‘s purpose is to improve outcomes and quality of life for women with gynaecological cancer by conducting research.
We conduct and promote clinical trials and undertake multidisciplinary research into the causes, prevention and treatments of gynaecological cancers.
Research Community Volunteers will have the opportunity to contribute to ANZGOG research at every stage of the development process.
Community volunteers will lend their voices to research discussions sharing their personal perspective and representing the broader views of people with lived experience of gynaecological cancer.
Opportunities range from sharing your lived experience as a participant on a research grant working party or a Trial Management Committee, through to Research Advisor and Expert roles requiring additional levels of education and expertise in research analysis.
Gynaecological cancer research is critically needed but critically underfunded. WomenCan is the fundraising arm of ANZGOG, supporting ANZGOG by funding our programs to improve life for women with gynaecological cancer.
WomenCan’s mission is to engage the community to fund pioneering discoveries that will enable women with a gynaecological cancer to live better and live longer.
WomenCan believes the power of the collective, united in a common purpose, can make a real difference in the lives of women with gynaecological cancers.
ANZGOG’s Survivors Teaching Students (STS) Program is a ground-breaking volunteer program that brings gynaecological cancer survivors and caregivers into the classrooms of health professional students to teach them about women’s experiences with the diseases.
Survivors and caregivers are in a unique position to help students understand the ‘lived experience’ of a gynaecological cancer, including the psychosocial impact, and the importance of timely diagnosis, good health communication and compassionate care.
By joining STS and sharing your story, you will have the opportunity to impact the future care of women diagnosed with a gynaecological cancer, with participating students reporting not only increased understanding of gynaecological cancers but also a deeper understanding of the patient experience to take forward into their practice.
Since the program began at ANZGOG in 2017, our volunteers have shared their stories with more than 11,000 students across Australia and New Zealand.
